AbbVie Inclusion In Medicare Drug Talks Fails To Justify Lawsuit, Court Rules
AbbVie Inc. (NYSE:ABBV), the manufacturer of Imbruvica, is at the center of a constitutional challenge to the federal government's new Drug Price Negotiation Program.
Benzinga ·